pravastatin has been researched along with Experimental Radiation Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigueperse, J; Bourgier, C; Bourhis, J; François, A; Gilliot, O; Haydont, V; Rivera, S; Vozenin-Brotons, MC | 1 |
1 other study(ies) available for pravastatin and Experimental Radiation Injuries
| Article | Year |
|---|---|
Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection.
Topics: Animals; Apoptosis; Cell Line, Tumor; Collagen; Connective Tissue Growth Factor; Drug Evaluation, Preclinical; Female; Fibrosis; HeLa Cells; HT29 Cells; Humans; Ileum; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Nude; Pravastatin; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Wistar | 2007 |